欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号AT/H/0683/001
药品名称Flexbumin
活性成分
    • albumin human 200.0 g/l
剂型Solution for infusion
上市许可持有人Baxalta Innovations GmbH, Austria
参考成员国 - 产品名称Austria (AT)
Flexbumin 200 g/l - Infusionslösung
互认成员国 - 产品名称
    • Denmark (DK)
      Flexbumin
    • Malta (MT)
      Flexbumin 200g/l
    • Netherlands (NL)
      Flexbumin 200 g/l, oplossing voor infusie
    • Iceland (IS)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Norway (NO)
    • Poland (PL)
      Flexbumin 200 g/l
    • Latvia (LV)
      Flexbumin 200 g/l šķīdums infūzijām
    • Lithuania (LT)
      Flexbumin 200 g/l infuzinis tirpalas
    • Estonia (EE)
      FLEXBUMIN 200 G/L
    • Hungary (HU)
      Flexbumin 200 g/l oldatos infúzió
    • Cyprus (CY)
      flexbumin 200g/l 27M0014
    • Czechia (CZ)
      Flexbumin 200 g/l
    • Slovakia (SK)
      Flexbumin 200 g/l
    • Slovenia (SI)
许可日期2008/04/05
最近更新日期2024/12/23
药物ATC编码
    • B05AA01 albumin
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase